Log in
NASDAQ:APDN

Applied DNA Sciences Stock Forecast, Price & News

$7.52
+0.34 (+4.74 %)
(As of 11/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$6.95
Now: $7.52
$7.70
50-Day Range
$6.57
MA: $7.28
$8.16
52-Week Range
$2.52
Now: $7.52
$16.39
Volume947,420 shs
Average Volume1.07 million shs
Market Capitalization$38.68 million
P/E RatioN/A
Dividend YieldN/A
Beta1.59
Applied DNA Sciences, Inc. engages in polymerase chain reaction-based DNA manufacturing that enables in vitro diagnostics, and pre-clinical nucleic acid-based therapeutic drug candidates in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNature T molecular tags, which are tagging and authentication systems for use in brand protection efforts and raw material source compliance programs; and fiberTyping, a test of native cotton fiber DNA. It also provides Smart DNA, a tagging solution for vehicle and home asset marking, as well as for commercial and government use; Beacon locked optical markers, which create a protected covert screening tool that can be adapted to packaging, security labels, and highÂ-value assets through inks, varnishes, and coatings; and SigNify IF portable DNA readers. In addition, the company offers Applied DNA Sciences Portal, a software platform that enables customers to manage the security of company-marked goods; and DNA Transfer Systems and Cannabis Tracking System for real-time monitoring. Further, it provides CertainT Supply Chain Platform that provides proof of product claims for materials, items, or products; and Triathlon PCR systems that allow for the large-scale production of specific DNA sequences. Additionally, the company offers contract research services; and various RNA based drug and biologic customers for preclinical studies. It also develops tests in virology, for the detection of COVID-19, and in oncology, for the detection and enumeration of invasive circulating tumor cells. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
Applied DNA Sciences logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.37 out of 5 stars


Industry, Sector and Symbol

Industry Miscellaneous business services
Sub-IndustryN/A
Current SymbolNASDAQ:APDN
CUSIPN/A
Phone631-840-8800
Employees51

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.39 million
Book Value($0.71) per share

Profitability

Net Income$-8,620,000.00
Net Margins-304.46%

Miscellaneous

Market Cap$38.68 million
Next Earnings Date12/10/2020 (Estimated)
OptionableOptionable
$7.52
+0.34 (+4.74 %)
(As of 11/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive APDN News and Ratings via Email

Sign-up to receive the latest news and ratings for APDN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Applied DNA Sciences (NASDAQ:APDN) Frequently Asked Questions

How has Applied DNA Sciences' stock price been impacted by Coronavirus?

Applied DNA Sciences' stock was trading at $4.10 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, APDN stock has increased by 83.4% and is now trading at $7.52.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Applied DNA Sciences?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Applied DNA Sciences in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Applied DNA Sciences
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Applied DNA Sciences?

Wall Street analysts have given Applied DNA Sciences a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Applied DNA Sciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Applied DNA Sciences' next earnings date?

Applied DNA Sciences is scheduled to release its next quarterly earnings announcement on Thursday, December 10th 2020.
View our earnings forecast for Applied DNA Sciences
.

How were Applied DNA Sciences' earnings last quarter?

Applied DNA Sciences, Inc. (NASDAQ:APDN) issued its quarterly earnings results on Thursday, August, 6th. The technology company reported ($0.72) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.62) by $0.10. The technology company earned $0.43 million during the quarter, compared to the consensus estimate of $0.50 million. Applied DNA Sciences had a negative return on equity of 180.24% and a negative net margin of 304.46%.
View Applied DNA Sciences' earnings history
.

What price target have analysts set for APDN?

2 analysts have issued 12-month price targets for Applied DNA Sciences' shares. Their forecasts range from $20.00 to $21.00. On average, they anticipate Applied DNA Sciences' share price to reach $20.50 in the next year. This suggests a possible upside of 172.6% from the stock's current price.
View analysts' price targets for Applied DNA Sciences
.

Are investors shorting Applied DNA Sciences?

Applied DNA Sciences saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 442,400 shares, an increase of 21.2% from the October 31st total of 365,100 shares. Based on an average trading volume of 181,600 shares, the days-to-cover ratio is presently 2.4 days. Approximately 10.1% of the company's shares are short sold.
View Applied DNA Sciences' Short Interest
.

Who are some of Applied DNA Sciences' key competitors?

What other stocks do shareholders of Applied DNA Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Applied DNA Sciences investors own include Inovio Pharmaceuticals (INO), Advanced Micro Devices (AMD), Ekso Bionics (EKSO), Micron Technology (MU), Arbutus Biopharma (ABUS), VBI Vaccines (VBIV), Gilead Sciences (GILD), Vaxart (VXRT), Sorrento Therapeutics (SRNE) and Intel (INTC).

Who are Applied DNA Sciences' key executives?

Applied DNA Sciences' management team includes the following people:
  • Dr. James A. Hayward Ph.D., Sc.D., Chairman, Pres & CEO (Age 66, Pay $249.31k)
  • Ms. Beth M. Jantzen CPA, CPA, Chief Financial Officer (Age 44, Pay $221.54k)
  • Ms. Judith Murrah, Chief Information Officer & Sec. (Age 62, Pay $221.54k)
  • Mr. Sanjay M. Hurry, Exec. Director of Investor Relations & Corp. Communications
  • Mr. Clay Shorrock Esq., Gen. Counsel
  • Mr. John Shearman, Exec. Director of Marketing & Cannabis Bus.
  • Mr. Tony Benson, Managing Director of EMEA
  • Mr. Scott L. Anchin, Strategic Advisor & Director (Age 46)
  • Ms. Janice Meraglia, VP, Gov. & Military Programs
  • Ms. MeiLin Wan, VP of Textile Sales

What is Applied DNA Sciences' stock symbol?

Applied DNA Sciences trades on the NASDAQ under the ticker symbol "APDN."

Who are Applied DNA Sciences' major shareholders?

Applied DNA Sciences' stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (1.60%), Morgan Stanley (0.50%), Schonfeld Strategic Advisors LLC (0.21%), Schonfeld Strategic Advisors LLC (0.21%) and Squarepoint Ops LLC (0.20%).
View institutional ownership trends for Applied DNA Sciences
.

Which major investors are selling Applied DNA Sciences stock?

APDN stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, and BlackRock Inc..
View insider buying and selling activity for Applied DNA Sciences
.

Which major investors are buying Applied DNA Sciences stock?

APDN stock was bought by a variety of institutional investors in the last quarter, including Schonfeld Strategic Advisors LLC, Schonfeld Strategic Advisors LLC, and Squarepoint Ops LLC.
View insider buying and selling activity for Applied DNA Sciences
.

How do I buy shares of Applied DNA Sciences?

Shares of APDN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Applied DNA Sciences' stock price today?

One share of APDN stock can currently be purchased for approximately $7.52.

How big of a company is Applied DNA Sciences?

Applied DNA Sciences has a market capitalization of $38.68 million and generates $5.39 million in revenue each year. The technology company earns $-8,620,000.00 in net income (profit) each year or ($10.46) on an earnings per share basis. Applied DNA Sciences employs 51 workers across the globe.

What is Applied DNA Sciences' official website?

The official website for Applied DNA Sciences is www.adnas.com.

How can I contact Applied DNA Sciences?

Applied DNA Sciences' mailing address is 50 HEALTH SCIENCES DRIVE, STONY BROOK NY, 11790. The technology company can be reached via phone at 631-840-8800 or via email at [email protected]

This page was last updated on 12/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.